In addition, while a number of the agonists in Table 1 (Families 2-5) have norleucine at Rj, or an amino acid residue, in the practice of various embodiments of this invention a number of an amino acid residues (D or L) may be used at residue Ri, including without limitation, tyrosine, phenylalanine, aspartic acid, arginine, isoleucme, serine, histidine, glycine, cysteine, methionine, tryptophan, norvaline, ornithine, S-benzyl cysteine amino acid residues
This model is elegant but not fully proven
The 9 mg and 12 mg doses tested in TRIUMPH-4 are expected to form the therapeutic range, with 2 mg as the starting dose
GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring peptide originally found in human serum and shown to stimulate growth in hepatoma cells [1]
Hypothetically, histological analysis of the hind limb muscle may have confirmed the increased number of vessels and possibly enhanced vascular expression of vascular endothelial growth factor receptor 2 (VEGFR2) with BPC-157 influence